Moriwaka F, Satoh H, Ejima A, Watanabe C, Tashiro K, Hamada T, Matsumoto A, Shima K, Yanagihara T, Fukazawa T
Department of Neurology, Hokkaido University School of Medicine, Sapporo, Japan.
J Neurol Sci. 1993 Aug;118(1):38-42. doi: 10.1016/0022-510x(93)90243-r.
We evaluated the pathogenicity of mercury (Hg) and selenium (Se) which are supposed to be one of the risk factors in the development of amyotrophic lateral sclerosis (ALS). Hg and Se contents were measured in plasma, blood cells, scalp hair samples of 21 sporadic ALS patients and 36 controls, who included 19 patients with other neurological diseases, in Hokkaido, the northernmost island of Japan. Hg and Se levels in plasma and blood cells of ALS patients were significantly lower in advanced staged ALS patients than controls. Low Hg and Se contents in ALS, being correlated with their disabilities and nutritional conditions, would rather reflect the disease contracted states than the pathogenic roles in ALS.
我们评估了汞(Hg)和硒(Se)的致病性,它们被认为是肌萎缩侧索硬化症(ALS)发病的风险因素之一。在日本最北部岛屿北海道,对21例散发性ALS患者和36名对照者(包括19例患有其他神经系统疾病的患者)的血浆、血细胞和头皮毛发样本中的汞和硒含量进行了测量。晚期ALS患者血浆和血细胞中的汞和硒水平显著低于对照组。ALS患者体内汞和硒含量较低,与他们的残疾和营养状况相关,这更能反映疾病的患病状态,而非在ALS中的致病作用。